Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
CTX120 for Multiple Myeloma
Recruiting1 awardPhase 1
Toronto, Ontario
This trial is testing a new treatment called CTX120. It is aimed at patients with a type of blood cancer that has come back or not responded to other treatments. The goal is to see if CTX120 is safe and effective in these patients.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service